User:Jeremy S. Myers

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
Current revision (11:20, 14 August 2008) (view source)
 
(One intermediate revision not shown.)
Line 20: Line 20:
==Research interests==
==Research interests==
<!-- Feel free to add brief descriptions to your research interests as well -->
<!-- Feel free to add brief descriptions to your research interests as well -->
-
# Targeted Mass Spectrometry-based Proteomic
+
# Targeted Mass Spectrometry-based Proteomics
# Targeted Therapeutics
# Targeted Therapeutics
Line 32: Line 32:
==Selected Protocols==
==Selected Protocols==
*[[Myers:EGFR_IP]]
*[[Myers:EGFR_IP]]
 +
*[[Myers:synchronization]]

Current revision

Contents

Contact Info

(an artistic interpretation)
(an artistic interpretation)
  • Jeremy S. Myers, Ph.D.
  • AstraZeneca Fellow
  • Advanced Targeted Proteomics Team Leader
  • Vanderbilt University School of Medicine
  • Mass Spectrometry Research Center
  • Nashville, TN, U.S.A.
  • jeremy.myers@vanderbilt.edu

for more information visit: http://www.advancedtargetedproteomics.com

Education

  • 2003-2007 Postdoctoral Fellow
  • 2003 Ph.D., Louisiana State University
  • 1999 B.S., Bucknell University

Research interests

  1. Targeted Mass Spectrometry-based Proteomics
  2. Targeted Therapeutics

Publications (since 2007)

  1. Myers JS, Zhao R, Xu X, Ham AJ, Cortez D. Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res. 2007 Jul 15;67(14):6685-90. PMID: 17638878

Useful links

Selected Protocols

Personal tools